Cressey & Company
Originally a generalist company, Cressey & Company has gradually split into sector-specific specialist entities such as Thoma Bravo, the undisputed US technology leader, and Cressey & Company, a major player in the US healthcare sector.
Independent since 2008 and headed by its founder, Bryan Cressey, the firm now has 46 professionals, including 21 dedicated to investments and five to operations, spread across its two US offices, in Chicago and Nashville.
The company is wholly owned by its partners and has around $3bn under management.
A pioneer in healthcare investment
The team is renowned for its specialisation in the exclusive healthcare sector , and over a very long period. Very few players of comparable size have made as many deals in the targeted segment.
It capitalises on its extensive experience to invest in niche healthcare markets, where it is an undisputed expert in complex deals, special regulatory issues, specific reimbursement aspects, etc.
It relies on a network of outstanding experts in the US healthcare ecosystem (both in-house and external, renowned specialists in the private and public sectors with in-depth knowledge of our businesses, best practices, current regulations and risks).
A unique investment strategy in a vast ecosystem
- Cressey & Co specialises in investing in service providers,focusing on the growth and resilience of a $3Trn market, particularly in the context of an aging population and ongoing advances in medical technology,
- However, the firm excludes biosciences, med-techs and suppliers of diagnostic solutions from their investment portfolio,
- The firm's teams carry out in-depth, proactive analyses to identify the most promising sectors, includingfood for the elderly, ambulatory care, mobility support, home care, etc.
Disciplined operating procedures and stable returns
An analysis of the company's track record shows excellent performance and very low volatility of returns on investment since inception and across several economic cycles, which is rare among competitors in the healthcare sector.
Due diligence is carried out in-house through the teams' in-depth expertise, and transformation plans are laid out around proven roadmaps:
- Leading of high-volume transformative acquisitions (M&A),
- Expanding geographical coverage based on regional successes,
- Improved operational performance through team commitment in finance, HR, and sales & marketing.
Transformation plans laid out around proven roadmaps
The firm follows proven roadmaps to help the companies in which it invests create value:
- Leading high-volume transformative acquisitions (M&A),
- Expanding geographical coverage based on regional successes,
- Improved operational performance thanks to the commitment of the company's operating partners in finance, hR, and sales & marketing.
Cressey fund VII
Discover the new Vintage Altaroc Odyssey 2025
Discover the Vintage Altaroc Horizon
